期刊名称：ENDOCRINOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Endocrinology, the Society's oldest journal, has defined the science of endocrinology for most of the twentieth century. One of the most authoritative biomedical research journals in the world, it publishes 6,000 pages annually of the highest quality original work ranging from subcellular mechanisms to whole animal physiology. Topics include bone and mineral; growth factors; reproductive/steroids; neuroendocrinology/signal transduction; thyroid; and physiology. The low manuscript acceptance rate of 30% reflects the degree to which it is committed to the highest scientific standard. In 2002, Endocrinology ranked 15th out of 88 journals in the ISI category of Endocrinology and Metabolism, with an Impact Factor of 5.095 (overall ranking: 249rd out of 5876). Published monthly.
Instructions to Authors
Purpose and Scope
Endocrinology primarily publishes original subcellular biochemical and physiological studies. The Endocrine Society also publishes the following journals: Endocrine Reviews publishes scholarly review articles in all areas of experimental and clinical endocrinology on a bimonthly basis. The Journal of Clinical Endocrinology & Metabolism publishes endocrine and metabolic studies related to human and primate physiology and disease. Molecular Endocrinology published papers that use a molecular approach to study the regulatory mechanisms of hormones and related substances in nonprimate and primate cells.
General Information
Original investigative reports may be submitted to Endocrinology as a regular manuscript or as a Brief Communication. The former may be of any length and the latter is limited to four (4) journal publication pages. Brief Communications are short reports that must contain new observations of unusual interest, importance, or immediate benefit to the endocrine community. They should not be preliminary reports or incomplete studies. Papers whose main emphasis is methodological must be submitted as Brief Communications. Brief communications are organized as indicated below for regular manuscripts except that should not contain more than 30 references. In addition, Brief Communications can only be submitted electronically on the Endocrinology E-review site (http://endo.endojournals.org/).
Manuscripts not written in idiomatic English or not conforming to the specifications set forth here will not be reviewed, but returned to the author for necessary revision. Manuscripts submitted to Endocrinology are evaluated by confidential peer review. Authors are given two (2) months to revise a manuscript that is not rejected. Editorial policy allows only one revision of a manuscript. A manuscript returned to the Editorial Office after two (2) months will be treated as a new submission. Authors must present a written request (via email or regular mail) to the Editor-in-Chief for possible extension of any due date associated with a manuscript returned for revision. A rejected manuscript that is re-submitted will be treated and dated as a new manuscript. Manuscripts will not be returned after review.
Manuscript Submission
Electronic Submission
Endocrinology encourages electronic manuscript submission. See the link to E-Review on the Endocrinology web page (http://endo.endojournals.org/).If you have never had a manuscript reviewed through E-Review, click "New to Rapid Review" on the E-Review page to create an author account. If you already have an author account from a previous submission, enter your user name and password to submit a new or revised manuscript.
Submission by Mail
Note to Authors
Beginning July 1, 2003, there will be a $200 fee assessed for all submissions by mail. There will be no submission fee for electronic submissions.
Authors who are unable to submit electronically are encouraged to first create a manuscript record in E-Review in order to expedite the review process. See the instructions above. When you have completed the manuscript submission form, click "Submit Manuscript by Mail." Please note that submission by mail will result in a significant delay in the review process.
Send manuscripts by mail to:
Jeffrey E. Pessin, Ph.D., Editor-in-Chief
Endocrinology Editorial Office
8401 Connecticut Avenue, Suite 900
Chevy Chase, MD 20815-5817 USA
301-951-2615; Fax: 301-951-2617
Email: sherman@endo-society.org
All submissions MUST INCLUDE:
- Cover letter stating the authors¡¯ wish that the manuscript be evaluated for publication in Endocrinology. This letter must list the title and all authors of the paper, the submission package contents, and may suggest specific reviewers and/or request their exclusion.
- Completed Copyright Assignment & Affirmation of Originality form, which is available at http://endo.endojournals.org/misc/origcopy.pdf
MAILED COPIES MUST INCLUDE THE ABOVE PLUS
- Original + one copy of manuscript.
- Disk copy of manuscript text file.
- Two complete sets of original figures.
- Separate disk containing figures prepared according to guidelines at Cadmus Digital Art.
- NOTE: There is no submission fee for The Endocrine Society journals.
Manuscript Preparation
General Format
The manuscript should be typed, with all text double-spaced (including references, tables and legends). Use wide (1" or larger) margins, and print on one side only of standard paper. Number all pages. The following sections must begin on separate pages: title page, references, footnotes, tables, legends.
Title
The title page should include the following:
¡¤ Full title (a concise statement of the article¡¯s major contents)
¡¤ Abbreviated title of not more than 40 characters for page headings
¡¤ Authors' names and institutions
¡¤ Corresponding author's address, telephone and fax numbers, and email address
¡¤ Name and address of person to whom reprint requests should be addressed
¡¤ At least three key words to support indexing and information retrieval
¡¤ Any grants or fellowships supporting the writing of the paper
Abstract
¡¤ Do not exceed 250 words
¡¤ Briefly describe in complete sentences the purpose of the investigation, the methods used, the results obtained, and the principal conclusions
¡¤ Do not refer to the text or references
¡¤ Write the abstract with a general audience in mind
Introduction
The article should begin with a brief introductory statement that places the work to follow in historical perspective and explains its intent and significance.
Experimental Subjects
It is assumed that all clinical investigation described in the paper was conducted in accordance with the guidelines in The Declaration of Helsinki and has been formally approved by the appropriate institutional review committees, or equivalent. All manuscripts should indicate that such approval was obtained. The study populations should be described in detail. In many studies details of age, race, and sex are important. In experiments involving human subjects, it should be documented that informed consent was obtained from the subjects and that an institutional human research committee had approved the investigations.
In text, tables, and figures subjects must be identified by number or letter rather than by initials or names.
Photographs of patients¡¯ faces should be included only if scientifically relevant. Authors must obtain written consent from the patient for use of such photographs. For further details, see the Ethical Guidelines.
Experimental Animals
A statement confirming that all animal experimentation described in the submitted manuscript was conducted in accord with accepted standards of humane animal care, as outlined in the Ethical Guidelines, should be included in the manuscript.
Materials and Methods
These should be described and referenced in sufficient detail for other investigators to repeat the work. The source of hormones, unusual chemicals and reagents, and special pieces of apparatus should be stated. For modified methods only the modifications need be described.
Results and Discussion
The Results section should briefly present the experimental data in text, tables, or figures (for details on the preparation of tables and figures, see below). The Discussion should focus on the interpretation and significance of the findings with concise objective comments that describe their relation to other work in that area. Results & Discussion may be presented separately or combined into a single section.
Figure Legends
Figure legends and titles should be submitted on a separate page from the figures. Figure legends should add meaning and significance to the figure, and should not require reference back to the text.
Figures
Digital art: Authors are encouraged to submit digital art to expedite the review and publication processes. Please review the detailed instructions for preparing digital art at Cadmus Digital Art. E-mail queries can be sent to Cadmus Digital Art. Authors must also review the instructions for submitting through E-Review.
Sizing and labeling the figure: The author is responsible for providing digital art that has been properly sized, cropped, and has adequate space between images. Plan the size of the figure to fill 1, 1.5, or 2 columns in the printed journal (see chart below for dimensions). In most cases, figures should be prepared for 1-column width. Produce original art at the size it should appear in the printed journal.
1 column = 18 picas, 7.5 cm, 3.0 in
1.5. columns = 30 picas, 12.5 cm, 5.0 in
2 columns = 38 picas, 16.0 cm, 6.4 in
At 100% size, no lettering should be smaller than 8 point (0.3 cm high) or larger than 12 point (0.4 cm high). Use bold and solid lettering. Lines should be thick, solid, and no less than 1-point rule. Avoid the use of reverse type (white lettering on a darker background). Avoid lettering on top of shaded or textured areas. Titles should be clear and informative. Keep wording on figures to a minimum, and confine any explanation of figures to their separate-page legends. Label only one vertical and one horizontal side of a figure. Freehand lettering or drawing is unacceptable.
Special requirements for 4-color art: Save files in CMYK mode (cyan-magenta-yellow-black). Color saturation of the shadow portion cannot exceed 280% (%cyan + %magenta + %yellow + %black cannot exceed 280%).
Shading: Avoid the use of shading, but if unavoidable, use a coarse rather than a fine screen setting (80-100 line screen is preferred). Avoid 1-20% and 70-99% shading; make differing shades vary by at least 20%, i.e., 25%, 45%, 65%. Instead of shading, denote variations in graphs or drawings by cross-hatching; solid black; or vertical, horizontal, or diagonal striping. Avoid the use of dots.
Grouped figures: For grouped figures, indicate the layout in a diagram. Place grouped figures so that they can be printed in 1 column width with uniform margins. Indicate magnification in the legends and by internal reference markers in the photographs. Their length should represent the fraction or multiple of a micrometer, appropriate to the magnification.
Hard copy submissions: Authors must submit two original sets of figures. In soft pencil or as a typed adhesive label on the back of each figure, indicate the following: 1) figure number; 2) corresponding author's name; 3) orientation (top). Because the figures will be scanned for on-line review, they must also be labeled with the figure number on the front of each figure. Figures must be clean and neat. Avoid writing in ink on the back of figures. Surface smoothness is critical: avoid tape and creases. Do NOT mount figures.
Graphs: Graphs with axis measures containing very large or small numbers should convert to easily readable notations. Example: For an ordinate range of "counts per minute" values from 1,000 to 20,000, the true value may be multiplied by 10-3 (scale would read from 1 to 20) and the ordinate axis display "cpm (x10-3)." Similarly, for a Scatchard plot with values ranging from 0.1 to 2 femtomolar (10-15 M), the scale may run from 0.1 to 2 with the abscissa labeled "M(x1015)." Three-dimensional bar graphs will not be published if the information they refer to is only two-dimensional.
Tables
Submit tables as printed text on plain paper only. Photographs of tables are not acceptable. Each table must have a concise heading and be constructed as simply as possible; it must be intelligible without reference to the text. At the foot of the table a description of experimental conditions may appear together with footnotes. Tables that duplicate text or figures are not acceptable. The width of the table must be designed to occupy one or both journal columns: no more than 4 table columns (one journal column), or no more than 8-10 table columns (two journal columns). See the chart under Figures for dimensions.
Acknowledgments (not required for submission)
A note of acknowledgment is appropriate recognition for contributors who may not be listed as authors, or for noting grant support of the research.
References
References to the literature should be cited in numerical order (in parentheses) in the text and listed in the same numerical order at the end of the manuscript on a separate sheet or sheets. There must be only one reference to a number.
The number of references cited should be kept to a reasonable minimum; to this end, appropriate recent reviews should be cited whenever possible.
Examples of the reference style that should be used are given below. The titles of journals should be abbreviated according to the style used in the Index Medicus.
Journal articles and abstracts: List all authors. The citation of unpublished observations, of personal communications, and of manuscripts in preparation or submitted for publication is not permitted in the bibliography. Such citations should be inserted at appropriate places in the text, in parentheses and without serial number, or be presented in the footnotes. The citation of manuscripts in press (i.e., accepted for publication) is permitted in the bibliography; the name of the journal in which they appear must be supplied. If references to personal communications are made, authors are encouraged to keep written proof of the exchange. If it is necessary to cite an abstract because it contains substantive data not published elsewhere, it must be designated at the end of the reference [e.g., . . .68:313 (Abstract)]. The author is responsible for the accuracy of references.
Books: List all authors or editors.
Sample References
- Binoux M, Hossenlopp P 1986 Insulin-like growth factor (IGF) and IGF-binding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509-514
- MacLaughlin DT, Cigarros F, Donahoe PK 1988 Mechanism of action of Mullerian inhibiting substance. Program of the 70th Annual Meeting of The Endocrine Society, New Orleans, LA, 1988, p 19
- Bonneville F, Cattin F, Dietemann J-L 1986 Computed tomography of the pituitary gland. Heidelberg: Springer-Verlag; 15-16
- Burrow GN 1987 The thyroid: nodules and neoplasia. In: Felig P, Baxter JD, Broadus AE, Frohman LA, eds. Endocrinology and metabolism. 2nd ed. New York: McGraw-Hill; 473-507
For general aid in the preparation of manuscripts, authors should consult: CBE Style Manual: A Guide for Authors, Editors and Publishers. 5th ed. Bethesda, MD: Council of Biology Editors; 1983
Units of Measure
Results should be expressed in metric units. Syst¨¨me Internationale (SI units) must be added in parentheses. Temperature should be expressed in degrees Celsius (e.g., 28 C) and time of day using the 24-hour clock (e.g., 0800 h, 1500 h). Do not express molecular weight in daltons. Molecular weight is considered to be the relative molecular mass of a substance, i.e., the ratio of the mass of one molecule of the substance to 1/12 of the mass of one atom of carbon 12. Therefore, molecular weight is dimensionless. The dalton is a unit of mass equivalent to 1/12 of the mass of one atom of carbon 12.
Manuscripts Reporting New Amino Acid or Nucleotide Sequences
Manuscripts reporting amino acid or nucleotide sequences of proteins with sequences already known from other tissues or species will be considered only if they provide new biological insight. Manuscripts dealing with partial sequence data are not likely to be considered. The Endocrine Society has established policy that deals with submission of new protein or nucleic acid sequences. When a manuscript is accepted that contains novel sequences, such sequences must be deposited in the appropriate database (such as GenBank) and an accession number obtained before the manuscript is sent to the printer. It is recommended that the following statement containing the assigned accession number be inserted as a footnote: "These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number Ul2345."
Manuscripts Reporting on Novel Compounds
Manuscripts describing experiments with new compounds must provide their chemical structures. For known compounds, the source and/or literature reference to the chemical structure and characterization must be provided.
Validation of Data and Statistical Analysis
Assay validation: Bioassay and radioimmunoassay potency estimates should be accompanied by an appropriate measure of the precision of these estimates. For bioassays, these usually will be the standard deviation, standard error of the mean, coefficient of variation, or 95% confidence limits. For both bioassays and radioimmunoassays, it is necessary to include data relating to within-assay and between-assay variability. If all relevant comparisons are made within the same assay, the latter may be omitted. Authors should be aware that the precision of a measurement depends upon its position on the dose-response curve.
In presenting results for new assays, it is necessary to include data on the following: 1) within-assay variability; 2) between-assay variability; 3) slope of the dose-response curve; 4) mid-range of the assay; 5) least-detectable concentration (concentration resulting in a response two standard deviations away from the zero dose response); 6) data on specificity; 7) data on parallelism of standard and unknown and on recovery; and 8) comparison with an independent method for assay of the compound. When radioimmunoassay kits are utilized or hormone measurements are conducted in other than the authors' laboratories and the assay is central to the study, data regarding performance characteristics should be included.
Pulse analysis: Data from studies of pulsatile hormone secretion should be analyzed using a validated, objective pulse detection algorithm. The algorithm used should require that false-positive rates of pulse detection be defined in relation to the measurement error of the data set being analyzed, and the methods used to determine the measurement error should be described. The author(s) also should describe the methods used: 1) to deal with missing or undetectable values; 2) to determine peak frequency, interpeak interval, and pulse amplitude; and 3) For statistical comparisons of peak parameters.
Data Analysis: It is the author's responsibility to document that the results are reproducible and that the differences found are not due to random variation. No absolute rules can be applied, but in general quantitative data should be from no fewer than three replicate experiments. Appropriate statistical methods should be used to test the significance of differences in results. The term "significant" should not be used unless statistical analysis was performed, and the probability value used to identify significance (e.g., P > 0.05) should be specified.
When several t tests are employed, authors should be aware that nominal probability levels no longer apply. Accordingly, the multiple t test, multiple range test, or similar techniques to permit simultaneous comparisons should be employed. Also, in lieu of using several t tests, it is often more appropriate to utilize an analysis of variance (ANOVA) to permit pooling of data, increase the number of degrees of freedom, and improve reliability of results. Authors should use appropriate nonparametric tests when the data depart substantially from a normal distribution.
Analysis of variance tables should not be inserted in manuscripts. F values with the degrees of freedom as subscripts together with the P values are sufficient.
In presenting results of linear regression analyses, it is desirable to show 95% confidence limits.
When data points are fitted with lines (as in Scatchard or Lineweaver-Burk plots), the method used for fitting (graphical, least squares, computer program) should be specified. If differences in slopes and/or axis intercepts are claimed for plotted lines, these should be supported by statistical analysis.
Useful references for statistical methods are McArthur, J. W., and T. Colten (eds.), Statistics in Endocrinology, MIT Press, Cambridge, 1970, and Finney, D. J., Statistical Method in Biologic Assays, ed. 2, Griffin, London, 1967.
Supplemental Data
Supplemental Data allows authors to enhance papers in Endocrinology by making additional substantive material available to readers. Supplemental Data may take the form of figures, tables, datasets, derivations, or videos, and is published only in Endocrinology online; it does not appear in the printed version of the journal. Authors who wish to include Supplemental Data should state so in the cover letter when the manuscript is submitted.
Supplemental Data files should be submitted through E-Review at the time of manuscript submission, and will be reviewed along with the manuscript. The files should be uploaded in the field marked "Upload Supplemental Data Files", and should NOT be attached with the manuscript and figure files. Authors submitting hard copies may submit Supplemental Data on a separate disk clearly marked "Supplemental Data for the Web", and with the manuscript title, corresponding author's name, file names, and name and version of programs used to create the files. Authors should refer to the Supplemental Data in the manuscript at an appropriate point in the text or figure/table legend.
The file formats listed below may be used for Supplemental Data. Provide a brief description of each item in a separate HTML or Word file (i.e., figure or table legends, captions for movie or sound clips, etc.). Do not save figure numbers, legends, or author names as part of an image. File sizes should not exceed 5 MB. Images should not exceed 500 pixels in width or height. Do not use tabs or spaces for Word or WordPefect tables; please use the table functions available within these word processing programs to prepare tables. For web pages, provide a complete list of files and instructions for creating directories.
htm, HTML*
.jpg, JPEG image*
.gif, Graphical image
.pdf, Adobe Portable Document Format
.xls, MS Excel Spreadsheet
.mov Quick Time
.wav, Sound
.doc, MS Word 6 documents**
.txt, Plain ASCII*
*These files can be viewed directly on standard web browsers.
**MS Word may be used for text only.
Publication and Production Guidelines
Electronic Editing
For hard copy submissions, authors must submit electronic diskettes of the final accepted version of their manuscripts along with the typed revised manuscript. Please be sure that the file you send is the most recent version of the manuscript, and that it matches the printed copy that was accepted for publication. The file should contain all parts of the manuscript text in one file. Mathematics and tabular material, however, will be processed in the traditional manner and may be excluded from the diskette file. Digital art must be submitted on a separate disk.
The journal does not assume responsibility for errors in conversion of customized software, newly released software, or special characters.
Please label the outside of the diskette with the journal name; manuscript number; senior author's name, telephone and fax numbers; name of the file. Please be sure to also include the following information: name used to access file on diskette; type of hardware used (e.g., IBM/PS2); operating system and version (e.g., DOS 3.3); word processing program and version (e.g., WordPerfect 5.0); special characters used in the file (e.g., Greek, mathematical symbols).
Authors preparing diskettes on Macintosh computers should not use the Fastsave option. Files in ASCII can also be used, but are not preferred.
Proofs and Reprints
Proofs and a reprint order are sent to the corresponding author unless the Editorial Office is advised otherwise. The author should designate by footnote on the title page of the manuscript the name and address of the person to whom reprint requests should be directed. Questions about reprints should be referred to Cadmus Professional Communications at 410-819-3912 (direct) or 800-407-9190 (toll-free).
Page and Other Charges
There is no submission fee for The Endocrine Society journals. There will be a charge of $90 per printed page in the journal. There will be a charge of $450 per color figure. Queries on page charges may be directed to Joy Williams at Cadmus Professional Communications (410-691-6439; fax 410-684-2792). In extraordinary cases, on appeal by the author, the Publications Committee may consider waiving some of the color charges.
Archiving
The editorial office will retain all manuscripts and related documentation (correspondence, reviews, etc.) for 12 months following the date of publication or rejection.
Editorial Board
All correspondence to Endocrinology should be addressed to:
Dr. Jeffrey E. Pessin, Editor-in-Chief
Endocrinology
8401 Connecticut Avenue, Suite 900
Chevy Chase, MD 20815-5817
Phone: 301-951-2615
Fax: 301-951-2617
endocrinology@endo-society.org
Abdul B. Abou-Samra
John S. Adams
Gail Adler
Dennis L. Andress
Jane Aubin
Indrani C. Bagchi
Jacques Balthazart
Timothy Bartness
Michael Baum
Gerhard Baumann
William Baumbach
Francis Bayard
Fuller W. Bazer
Nira Ben-Jonathan
Michel Bernier
Robert M. Bigsby
Maria Luisa Brandi
Gregory A. Brent
Patricia Brubaker
Kerry Burnstein
Alessandro Capponi
John R. G. Challis
Bandana Chatterjee
Bentley Cheatham
Ching-Ling Chen
William W. Chin
Barbara J. Clark
Christine Clarke
Colin M. Clay
Thomas L. Clemens
Pinchas Cohen
Sheila Collins
Orla M. Conneely
Robert V. Considine
John S. Davis
Eleanor Davies
Richard Day
Robert Day
E. Ronald de Kloet
Maria B. Demay
Dirk G. de Rooij
Errol B. De Souza
Geert J. DeVries
Sudhansa K. Dey
Richard P. DiAugustine
Anne Dorrance
Colin Dunstam
Martin Dym
Richard A. Easom
Edward M. Eddy
Josephine M. Egan
Joel K. Elmquist
Ella Englander
Jacques Epelbaum
Robert V. Farese, Sr.
Riaz Farookhi
Asgerally T. Fazleabas
Jock Findlay
Joanne Fortune
John L. Fowlkes
Stuart J. Frank
Marc Freeman
Peter A. Friedman
Adolfo Garcia-Ocana
Jack Geller
Guela Gibori
Linda Giudice
Andrea C. Gore
George Greeley
Joel Habener
Dale Hales
Geoffrey Hammond
Victor K. M. Han
Matthew P. Hardy
Peter J. Havel
Mark L. Heiman
Lothar Hennighausen
Allen E. Herbison
Miles Herkenham
James Herman
Anthony Hollenberg
Jeff M. P. Holly
George G. Holz
Tamas Horvath
Aaron Hsueh
Willa A. Hsueh
Mary Hunzicker-Dunn
Lothar Jennes
Sissy M. Jhiang
Katia Karalis
Richard H. Karas
Shigeaki Kato
Sundeep Khosla
Don Kimmel
Rhonda Kineman
William Kinlaw
Irwin Klein
Leonard D. Kohn
John Kopchick
Anjaneyulu Kowluru
Peter Kushner
P. Reed Larsen
Jack L. Leonard
Symour Levine
C. Richard Lyttle
Neil James MacLusky
Ole D. Madsen
Hiroshi Maegawa
Denis Magoffin
Eleftheria Maratos-Flier
Margaret McCarthy
Thomas L. McCarthy
Donald P. McDonnell
Michael J. Meaney
Marvin L. Meistrich
William L. Miller
Suzanne M. Moenter
David D. Moore
Louis J. Muglia
Liam Murphy
Jerry L. Nadler
Sergio Ojeda
Philip Osdoby
Malcolm G. Parker
John J. Peluso
Donald W. Pfaff
J. Wesley Pike
Vincent Poitout
Arun Rajan
Basil Rapoport
Eva Redei
Samuel Refetoff
Marc Reitman
Steven M. Reppert
Gail P. Risbridger
Emilie Rissman
Mark S. Roberson
G. David Roodman
Michel F. Rossier
Bo Rudea
Jose Saez
Abhiram Sahu
Ernestina Schipaini
Michael W. Schwartz
Randy J. Seeley
Paul J. Shughrue
Alan Shuldiner
Theresa Siler-Khodr
Ann-Judith Silverman
Jacques Simard
Frank A. Simmen
Roy G. Smith
Wen-Chao Song
William E. Sonntag
James R. Sowers
Rene¡ä St-Araud
Robert A. Steiner
Mary Stenzel-Poore
Adriana Stoica
Charles Sultan
Gloria S. Tannenbaum
Eli Terasawa
Axel P. N. Themmen
Jean-Paul Thissen
Gary Thomas
Stuart Tobet
Yaron Tomer
Alexander Tsafriri
Henryk F. Urbanski
Hubert Vaudry
Robert Viger
David Wasserman
Michael J. Waters
David J. Waxman
Nancy L. Weigel
John H. White
Elizabeth M. Wilson
Teresa Wood
Juleen Zierath
Managing Editor: SCOTT C. HERMAN
Manuscript Coordinators: MEGAN PRICE, KATHI ROGERS
A PUBLICATION OF THE ENDOCRINE SOCIETY
| 
